Comparing Bipolar Transurethral Resection and Bipolar Enucleation of the Prostate for Treating Benign Prostatic Hyperplasia in Men Aged 50 to 80

What this Trial Is About

Researchers are evaluating the effectiveness and safety of two surgical methods for treating benign prostatic hyperplasia BPH, a condition causing lower urinary tract symptoms due to prostate enlargement. The study compares the long-standing standard method, transurethral resection of the prostate TURP, with a newer approach called bipolar transurethral enucleation of the prostate TUEP. TURP has been effective but carries risks such as serious complications and longer hospital stays, prompting exploration of safer, minimally invasive options. The trial involves two treatment groups one receiving TURP and the other receiving bipolar enucleation TUEP. Both procedures use bipolar diathermy via cystoscopy and are performed under spinal or general anesthesia according to usual care. TURP removes excess prostate tissue piece by piece, whereas TUEP anatomically enucleates the prostate. The study will assess these treatments over at least six months to one year to understand differences in symptom relief and safety. Participants will be men aged 50 to 80 years with significant urinary symptoms and prostate enlargement requiring surgery. Researchers will monitor catheter use, urinary symptoms, operative time, complications, and quality of life using various questionnaires during follow-up visits. Outcomes such as catheter-free status and symptom scores will be evaluated up to one year after surgery to compare the treatments benefits and risks.

Bipolar Resection vs Enucleation of Prostate